AtriCure, Inc. (ATRC) vs Precigen, Inc. (PGEN)
A side-by-side comparison of AtriCure, Inc. and Precigen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATRC
AtriCure, Inc.
$53.68HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PGEN
Precigen, Inc.
$7.55HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ATRC vs PGEN
growth of $100 · dividends reinvested · last 10yATRC +256.3% (+13.5%/yr)PGEN -73.0% (-12.3%/yr)ATRC compounded faster over this window
Log scale — wide-divergence pair
ATRC PGEN
ATRC vs PGEN: by the numbers
- •ATRC is the larger company ($2.73B vs $2.69B market cap).
- •ATRC is profitable (1.85% net margin) while PGEN runs a net loss (-183.98%).
- •ATRC grew revenue faster over the past five years (18.57% vs -21.26% CAGR).
Metrics side by side
Valuation
| Metric | ATRC | PGEN |
|---|---|---|
| P/E ratio | 252.97 | N/A |
| Forward P/E | N/A | 44.06 |
| P/S ratio | 4.79 | 31.40 |
| P/B ratio | 5.29 | 61.77 |
| EV / EBITDA | 75.80 | N/A |
| FCF yield | 1.88% | N/A |
Profitability
| Metric | ATRC | PGEN |
|---|---|---|
| Gross margin | 76.16% | 37.05% |
| Operating margin | 2.44% | -1100.78% |
| Net margin | 1.85% | -183.98% |
| ROE | 2.04% | -361.91% |
| ROIC | 2.04% | -28.02% |
Growth (annualized)
| Metric | ATRC | PGEN |
|---|---|---|
| Revenue CAGR (5Y) | 18.57% | -21.26% |
| Total return CAGR (5Y) | -4.06% | 8.79% |
Frequently asked
- Which has grown faster, ATRC or PGEN?
- Over the past five years, ATRC grew revenue faster — ATRC at a 18.57% CAGR versus PGEN at -21.26%.
- Is ATRC or PGEN more profitable?
- ATRC runs the higher net margin — ATRC at 1.85% versus PGEN at -183.98%.
- How have ATRC and PGEN total returns compared?
- Over the past 10 years, ATRC delivered 13.44% and PGEN delivered -12.26% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AtriCure P/E ratioAtriCure ROEPrecigen ROEAtriCure operating marginPrecigen operating marginAtriCure revenue growthPrecigen revenue growthAtriCure free cash flowPrecigen free cash flow
AtriCure & Precigen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.